Basic fibroblast growth factor in serum and urine of patients with head and neck cancer.

1998 ◽  
Author(s):  
A Leunig ◽  
S Tauber ◽  
R Spaett ◽  
G Grevers ◽  
M Leunig
Keyword(s):  
Head And Neck Cancer ◽  
Growth Factor ◽  
Head And Neck ◽  
Fibroblast Growth Factor ◽  
Basic Fibroblast Growth Factor ◽  
Neck Cancer ◽  
Fibroblast Growth ◽  
Serum And Urine

scholarly journals Expression of Fibroblast Growth Factor Binding Protein in Head and Neck Cancer

2009 ◽  
Vol 135 (9) ◽  
pp. 896 ◽  
Author(s):  
Weimin Li ◽  
Chuan Wang ◽  
Steven K. Juhn ◽  
Frank G. Ondrey ◽  
Jizhen Lin
Keyword(s):  
Head And Neck Cancer ◽  
Growth Factor ◽  
Head And Neck ◽  
Fibroblast Growth Factor ◽  
Neck Cancer ◽  
Binding Protein ◽  
Fibroblast Growth ◽  
Factor Binding

scholarly journals Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor

2012 ◽  
Vol 122 (7) ◽  
pp. 1539-1544 ◽  
Author(s):  
Larissa Sweeny ◽  
Zhiyong Liu ◽  
William Lancaster ◽  
Justin Hart ◽  
Yolanda E. Hartman ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Growth Factor ◽  
Head And Neck ◽  
Fibroblast Growth Factor ◽  
Neck Cancer ◽  
Fibroblast Growth Factor Receptor ◽  
Growth Factor Receptor ◽  
Cancer Growth ◽  
Fibroblast Growth

The role of serum basic fibroblast growth factor, estradiol and urine basic fibroblast growth factor in differentiating infantile haemangiomas from vascular malformations

2011 ◽  
Vol 26 (5) ◽  
pp. 191-196 ◽  
Author(s):  
X J Yang ◽  
Y H Jiang ◽  
J W Zheng ◽  
L Hong ◽  
Q Zhou ◽  
...  
Keyword(s):  
Growth Factor ◽  
Fibroblast Growth Factor ◽  
Basic Fibroblast Growth Factor ◽  
Cleft Lip ◽  
Vascular Malformations ◽  
Enzyme Linked Immunosorbent Assay ◽  
Fibroblast Growth ◽  
Infantile Haemangiomas ◽  
Serum And Urine

Objective To investigate the role of serum basic fibroblast growth factor (bFGF), estradiol (E2) and urine bFGF in differentiating infantile haemangiomas from vascular malformations. Method Between October 2007 and January 2009, 97 patients with haemangiomas and 25 patients with vascular malformations who had not been treated previously were included in this prospective study. Forty-eight patients with cleft lip and/or palate were selected as controls. The age of all subjects ranged from 1 to 30 months. The serum and urine levels of bFGF were determined by enzyme-linked immunosorbent assay (ELISA). The serum levels of E2 were examined via radioimmunoassay. All data were analysed with SPSS 11.5 software package. Results The concentration of serum and urine bFGF was significantly different among the three groups (haemangiomas, vascular malformations and controls) ( P = 0.027, P = 0.001). Significantly different urine bFGF levels were found in patients with proliferating and involuting haemangiomas ( P = 0.04). The serum E2 levels were significantly higher in patients with haemangiomas than vascular malformations ( P = 0.001) and controls ( P = 0.001). Conclusion Serum bFGF and E2 as well as urine bFGF can be used to supplement the clinical diagnosis of congenital vascular anomalies. Urine bFGF combined with serum E2 may be the most potential markers for diagnosing haemangiomas and determining the proliferating stage of haemangiomas.

Basic fibroblast growth factor and fibroblastic growth factor receptor–1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism

2007 ◽  
Vol 38 (1) ◽  
pp. 79-85 ◽  
Author(s):  
Pieter Bas Douwes Dekker ◽  
Nel J. Kuipers-Dijkshoorn ◽  
Hans J. Baelde ◽  
Andel G.L. van der Mey ◽  
Pancras C.W. Hogendoorn ◽  
...  
Keyword(s):  
Growth Factor ◽  
Head And Neck ◽  
Fibroblast Growth Factor ◽  
Basic Fibroblast Growth Factor ◽  
Growth Factor Receptor ◽  
Fibroblast Growth ◽  
Head And Neck Paraganglioma
Sign in / Sign up

Export Citation Format

Share Document